{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:31:16Z","timestamp":1790620276003,"version":"4.1.0"},"reference-count":119,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,8,30]],"date-time":"2025-08-30T00:00:00Z","timestamp":1756512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome affects 5\u201310% of women of reproductive age, with insulin resistance playing a central role in its pathophysiology in up to 80% of cases. This review aims to elucidate the molecular mechanisms by which insulin resistance disrupts ovarian function, contributing to menstrual irregularities and hyperandrogenism. It also evaluates current and emerging therapeutic strategies, with an emphasis on individualized management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A comprehensive review of recent literature was conducted, focusing on molecular studies, clinical trials, and meta-analyses related to insulin signaling pathways in polycystic ovary syndrome, as well as therapeutic interventions. Special attention was paid to ethnic variations, particularly in East Asian populations, and advances in genomic and metabolomic profiling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Polycystic ovary syndrome is characterized by selective insulin resistance, wherein metabolic insulin signaling is impaired, but steroidogenic and mitogenic pathways remain responsive, promoting hyperandrogenism and anovulation. East Asian women exhibit significant insulin resistance despite lower body mass index compared with Western populations. Insulin resistance in polycystic ovary syndrome also increases cardiometabolic risks and psychological burden. While lifestyle modification, insulin sensitizers, and hormonal therapy remain first-line treatments, novel approaches such as microbiome-targeted therapies and anti-inflammatory agents show promise.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Understanding the complex interplay between insulin resistance and ovarian dysfunction is crucial for effective polycystic ovary syndrome management. Integrating emerging molecular insights with digital health tools can facilitate personalized, multidisciplinary approaches that address both reproductive and metabolic aspects of polycystic ovary syndrome, ultimately improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary Sentence<\/jats:title>\n                    <jats:p>This study underscores the pivotal role of insulin resistance in ovarian dysfunction and advocates for integrated, technology-enhanced strategies to personalize PCOS management, thereby improving holistic patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/biolre\/ioaf197","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T11:45:35Z","timestamp":1756381535000},"page":"1340-1354","source":"Crossref","is-referenced-by-count":12,"title":["Insulin resistance in polycystic ovary syndrome: pathophysiological mechanisms of menstrual dysfunction and evidence-based treatment strategies"],"prefix":"10.1093","volume":"113","author":[{"given":"Xianrui","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Gynecology, Sichuan Provincial Center for Treatment of Gynecological and Breast Diseases, The Affiliated Hospital of Southwest Medical University , Luzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Sichuan Provincial Center for Treatment of Gynecological and Breast Diseases, The Affiliated Hospital of Southwest Medical University , Luzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Sichuan Provincial Center for Treatment of Gynecological and Breast Diseases, The Affiliated Hospital of Southwest Medical University , Luzhou ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,8,30]]},"reference":[{"key":"2025121605120262500_ref1","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121605120262500_ref2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","article-title":"Global prevalence of polycystic ovary syndrome in women worldwide: a comprehensive systematic review and meta-analysis","volume":"310","author":"Salari","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"2025121605120262500_ref3","doi-asserted-by":"publisher","first-page":"4325","DOI":"10.1210\/jc.2013-2040","article-title":"Renaming PCOS--a two-state solution","volume":"98","author":"Dunaif","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121605120262500_ref4","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"2025121605120262500_ref5","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121605120262500_ref6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Group REA-SPCW. Revised","year":"2003","journal-title":"Fertil Steril"},{"key":"2025121605120262500_ref7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede","year":"2010","journal-title":"BMC Med"},{"key":"2025121605120262500_ref8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"2025121605120262500_ref9","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1056\/NEJM199904293401703","article-title":"Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome","volume":"340","author":"Nestler","year":"1999","journal-title":"N Engl J Med"},{"key":"2025121605120262500_ref10","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1210\/jc.2003-030437","article-title":"Metformin therapy increases insulin-stimulated release of d-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome","volume":"89","author":"Baillargeon","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121605120262500_ref11","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","article-title":"Trends in insulin resistance: insights into mechanisms and therapeutic strategy","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"2025121605120262500_ref12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1172\/JCI118064","article-title":"Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus","volume":"96","author":"Ehrmann","year":"1995","journal-title":"J Clin Invest"},{"key":"2025121605120262500_ref13","first-page":"942","article-title":"Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121605120262500_ref14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"Boucher","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"2025121605120262500_ref15","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1042\/BCJ20160124","article-title":"Insulin signalling and glucose transport in the ovary and ovarian function during the ovarian cycle","volume":"473","author":"Dupont","year":"2016","journal-title":"Biochem J"},{"key":"2025121605120262500_ref16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/humupd\/dmp006","article-title":"Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis","volume":"15","author":"Toulis","year":"2009","journal-title":"Hum Reprod Update"},{"key":"2025121605120262500_ref17","doi-asserted-by":"publisher","DOI":"10.3390\/nu15163652","article-title":"Abdominal obesity in women with polycystic ovary syndrome and its relationship with diet, physical activity and insulin resistance: a pilot study","volume":"15","author":"Jurczewska","year":"2023","journal-title":"Nutrients"},{"key":"2025121605120262500_ref18","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"2025121605120262500_ref19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/metabo13020302","article-title":"Metabolic deregulations in patients with polycystic ovary syndrome","volume":"13","author":"Jabczyk","year":"2023","journal-title":"Metabolites"},{"key":"2025121605120262500_ref20","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nature04634","article-title":"Reactive oxygen species have a causal role in multiple forms of insulin resistance","volume":"440","author":"Houstis","year":"2006","journal-title":"Nature"},{"key":"2025121605120262500_ref21","doi-asserted-by":"publisher","first-page":"5614","DOI":"10.2174\/1381612822666160810111528","article-title":"Altered steroid metabolism and insulin signaling in PCOS endometria: impact in tissue function","volume":"22","author":"Or\u00f3stica","year":"2016","journal-title":"Curr Pharm Des"},{"key":"2025121605120262500_ref22","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"2025121605120262500_ref23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng.732","article-title":"Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3","volume":"43","author":"Chen","year":"2011","journal-title":"Nat Genet"},{"key":"2025121605120262500_ref24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41572-024-00511-3","article-title":"Polycystic ovary syndrome","volume":"10","author":"Stener-Victorin","year":"2024","journal-title":"Nat Rev Dis Primers"},{"key":"2025121605120262500_ref25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1210\/endrev\/bnae007","article-title":"The search for the causes of common hyperandrogenism, 1965 to circa 2015","volume":"45","author":"Rosenfield","year":"2024","journal-title":"Endocr Rev"},{"key":"2025121605120262500_ref26","doi-asserted-by":"publisher","first-page":"147062","DOI":"10.1016\/j.gene.2022.147062","article-title":"Loci on chromosome 12q13.2 encompassing erbb3, pa2g4 and rab5b are associated with polycystic ovary syndrome","volume":"852","author":"Alan Harris","year":"2023","journal-title":"Gene"},{"key":"2025121605120262500_ref27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.4239\/wjd.v12.i5.616","article-title":"Role of insulin and insulin resistance in androgen excess disorders","volume":"12","author":"Unluhizarci","year":"2021","journal-title":"World J Diabetes"},{"key":"2025121605120262500_ref28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12020-019-02085-7","article-title":"Nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"67","author":"Paschou","year":"2020","journal-title":"Endocrine"},{"key":"2025121605120262500_ref29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.fertnstert.2018.09.022","article-title":"Elevation of antiM\u00fcllerian hormone in women with polycystic ovary syndrome undergoing assisted reproduction: effect of insulin","volume":"111","author":"Liu","year":"2019","journal-title":"Fertil Steril"},{"key":"2025121605120262500_ref30","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1038\/s41467-024-49749-1","article-title":"Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"15","author":"Bahri Khomami","year":"2024","journal-title":"Nat Commun"},{"key":"2025121605120262500_ref31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMoa063971","article-title":"Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome","volume":"356","author":"Legro","year":"2007","journal-title":"N Engl J Med"},{"key":"2025121605120262500_ref32","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1210\/jc.2016-2963","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"Gibson-Helm","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121605120262500_ref33","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1007\/s40615-022-01295-6","article-title":"Mental health and PCOS information-sharing: interviews with health care providers in a low-income urban community","volume":"10","author":"Zamora","year":"2023","journal-title":"J Racial Ethn Health Disparities"},{"key":"2025121605120262500_ref34","doi-asserted-by":"publisher","first-page":"2477295","DOI":"10.1080\/07853890.2025.2477295","article-title":"Improvement of endocrine and metabolic conditions in patients with polycystic ovary syndrome through acupuncture and its combined therapies: a systematic review and meta-analysis","volume":"57","author":"Wu","year":"2025","journal-title":"Ann Med"},{"key":"2025121605120262500_ref35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1093\/ejendo\/lvaf030","article-title":"The PCOS phenotype in unselected populations study: ethnic variation in population-based normative cut-offs for defining hirsutism","volume":"192","author":"Bizuneh","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"2025121605120262500_ref36","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1038\/s41591-025-03592-z","article-title":"Single-cell profiling of the human endometrium in polycystic ovary syndrome","volume":"31","author":"Eriksson","year":"2025","journal-title":"Nat Med"},{"key":"2025121605120262500_ref37","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025121605120262500_ref38","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/brv.13166","article-title":"Testosterone mediates life-history trade-offs in female mammals","volume":"100","author":"Crespi","year":"2025","journal-title":"Biol Rev Camb Philos Soc"},{"key":"2025121605120262500_ref39","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The androgen excess and PCOS society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"2025121605120262500_ref40","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1093\/humrep\/dez185","article-title":"Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource","volume":"34","author":"Azziz","year":"2019","journal-title":"Hum Reprod"},{"key":"2025121605120262500_ref41","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"key":"2025121605120262500_ref42","doi-asserted-by":"publisher","first-page":"e2440583","DOI":"10.1001\/jamanetworkopen.2024.40583","article-title":"Prevalence, phenotypes, and comorbidities of polycystic ovary syndrome among Indian women","volume":"7","author":"Ganie","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2025121605120262500_ref43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/bmb\/ldac007","article-title":"Why are women with polycystic ovary syndrome obese?","volume":"143","author":"Barber","year":"2022","journal-title":"Br Med Bull"},{"key":"2025121605120262500_ref44","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/humrep\/deae294","article-title":"Prospective associations of adolescent obesity phenotypes with self-reported polycystic ovary syndrome diagnosis in young adulthood","volume":"40","author":"Reich","year":"2025","journal-title":"Hum Reprod"},{"key":"2025121605120262500_ref45","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/ejendo\/lvaf026","article-title":"Diabetic complications in women with type 2 diabetes and polycystic ovary syndrome","volume":"192","author":"Ollila","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"2025121605120262500_ref46","doi-asserted-by":"publisher","first-page":"1398017","DOI":"10.3389\/fendo.2024.1398017","article-title":"Interplay between lipid profile and anthropometric measures as indicators of cardiometabolic risk in women with polycystic ovary syndrome","volume":"15","author":"Jabczyk","year":"2024","journal-title":"Front Endocrinol"},{"key":"2025121605120262500_ref47","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.2147\/DDDT.S468147","article-title":"Impact of lipids on insulin resistance: insights from human and animal studies","volume":"18","author":"Elkanawati","year":"2024","journal-title":"Drug Des Devel Ther"},{"key":"2025121605120262500_ref48","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/biom15010051","article-title":"The role of the liver in the pathophysiology of PCOS: a literature review","volume":"15","author":"Alhermi","year":"2025","journal-title":"Biomolecules"},{"key":"2025121605120262500_ref49","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.fertnstert.2013.03.010","article-title":"Phenotypic comparison of Caucasian and Asian women with polycystic ovary syndrome: a cross-sectional study","volume":"100","author":"Wang","year":"2013","journal-title":"Fertil Steril"},{"key":"2025121605120262500_ref50","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.fertnstert.2016.08.033","article-title":"Relationship between polycystic ovary syndrome and ancestry in European Americans","volume":"106","author":"Bjonnes","year":"2016","journal-title":"Fertil Steril"},{"key":"2025121605120262500_ref51","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.rbmo.2010.04.032","article-title":"Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria","volume":"21","author":"Guo","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"2025121605120262500_ref52","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/humupd\/dmy007","article-title":"Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression","volume":"24","author":"Kakoly","year":"2018","journal-title":"Hum Reprod Update"},{"key":"2025121605120262500_ref53","doi-asserted-by":"publisher","first-page":"102217","DOI":"10.1016\/j.jogc.2023.102217","article-title":"Endocrinological and metabolic heterogeneity is low in Japanese women with polycystic ovary syndrome","volume":"46","author":"Baba","year":"2024","journal-title":"J Obstet Gynaecol Can"},{"key":"2025121605120262500_ref54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/rmb2.12026","article-title":"Clinical outcome of various metformin treatments for women with polycystic ovary syndrome","volume":"16","author":"Matsuzaki","year":"2017","journal-title":"Reprod Med Biol"},{"key":"2025121605120262500_ref55","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/ng.2384","article-title":"Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome","volume":"44","author":"Shi","year":"2012","journal-title":"Nat Genet"},{"key":"2025121605120262500_ref56","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/humrep\/deu352","article-title":"Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome","volume":"30","author":"Lee","year":"2015","journal-title":"Hum Reprod"},{"key":"2025121605120262500_ref57","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jog.13002","article-title":"Associations of insulin receptor and insulin receptor substrates genetic polymorphisms with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"42","author":"Shi","year":"2016","journal-title":"J Obstet Gynaecol Res"},{"key":"2025121605120262500_ref58","doi-asserted-by":"publisher","first-page":"e49220","DOI":"10.2196\/49220","article-title":"Appraising unmet needs and misinformation spread about polycystic ovary syndrome in 85,872 youtube comments over 12 years: big data infodemiology study","volume":"25","author":"Malhotra","year":"2023","journal-title":"J Med Internet Res"},{"key":"2025121605120262500_ref59","doi-asserted-by":"publisher","first-page":"999813","DOI":"10.3389\/fpubh.2022.999813","article-title":"Role of polycystic ovarian syndrome in developing psychological burden in Saudi Arabian females: a case control study","volume":"10","author":"Alamri","year":"2022","journal-title":"Front Public Health"},{"key":"2025121605120262500_ref60","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1530\/eje.1.01910","article-title":"Metformin administration improves endothelial function in women with polycystic ovary syndrome","volume":"152","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2025121605120262500_ref61","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12020-018-1692-3","article-title":"Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"62","author":"Brutocao","year":"2018","journal-title":"Endocrine"},{"key":"2025121605120262500_ref62","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0015-0282(02)03133-3","article-title":"N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome","volume":"77","author":"Fulghesu","year":"2002","journal-title":"Fertil Steril"},{"key":"2025121605120262500_ref63","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ecl.2004.08.002","article-title":"Neuroendocrine physiology of the early and late menopause","volume":"33","author":"Hall","year":"2004","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2025121605120262500_ref64","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2265.1980.tb02132.x","article-title":"The polycystic ovary syndrome","volume":"12","author":"Yen","year":"1980","journal-title":"Clin Endocrinol"},{"key":"2025121605120262500_ref65","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","article-title":"Clinical practice. Polycystic ovary syndrome","volume":"375","author":"McCartney","year":"2016","journal-title":"N Engl J Med"},{"key":"2025121605120262500_ref66","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1097\/AOG.0b013e3181a66843","article-title":"Premature ovarian failure","volume":"113","author":"Rebar","year":"2009","journal-title":"Obstet Gynecol"},{"key":"2025121605120262500_ref67","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121605120262500_ref68","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2025121605120262500_ref69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12958-025-01347-6","article-title":"High anti-M\u00fcllerian hormone level as a predictor of poor pregnancy outcomes in women with polycystic ovary syndrome undergoing in vitro fertilization\/intracytoplasmic sperm injection: a retrospective cohort study","volume":"23","author":"Zhao","year":"2025","journal-title":"Reprod Biol Endocrinol"},{"key":"2025121605120262500_ref70","doi-asserted-by":"publisher","first-page":"8498","DOI":"10.1038\/s41467-024-52898-y","article-title":"Superior metabolic improvement of polycystic ovary syndrome traits after GLP1-based multi-agonist therapy","volume":"15","author":"S\u00e1nchez-Garrido","year":"2024","journal-title":"Nat Commun"},{"key":"2025121605120262500_ref71","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1093\/humupd\/dmw042","article-title":"New concepts for an old problem: the diagnosis of endometrial hyperplasia","volume":"23","author":"Sanderson","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2025121605120262500_ref72","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"2025121605120262500_ref73","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2119\/molmed.2009.00118","article-title":"Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia","volume":"16","author":"Fornes","year":"2010","journal-title":"Mole Medi"},{"key":"2025121605120262500_ref74","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1423-0127-21-2","article-title":"Endometrial progesterone resistance and PCOS","volume":"21","author":"Li","year":"2014","journal-title":"J Biomed Sci"},{"key":"2025121605120262500_ref75","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1471-0528.2010.02525.x","article-title":"Uterine blood flow in pregnant patients with polycystic ovary syndrome: relationships with clinical outcomes","volume":"117","author":"Palomba","year":"2010","journal-title":"BJOG"},{"key":"2025121605120262500_ref76","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","article-title":"Endometrial function in women with polycystic ovary syndrome: a comprehensive review","volume":"27","author":"Palomba","year":"2021","journal-title":"Hum Reprod Update"},{"key":"2025121605120262500_ref77","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3892\/ol.2023.13754","article-title":"Risk of endometrial cancer in patients with polycystic ovarian syndrome: a meta-analysis","volume":"25","author":"Johnson","year":"2023","journal-title":"Oncol Lett"},{"key":"2025121605120262500_ref78","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"2025121605120262500_ref79","doi-asserted-by":"publisher","first-page":"2373199","DOI":"10.1080\/07853890.2024.2373199","article-title":"Obesity is associated with lower levels of negative emotions in polycystic ovary syndrome in clinical and animal studies","volume":"56","author":"Zhang","year":"2024","journal-title":"Ann Med"},{"key":"2025121605120262500_ref80","doi-asserted-by":"publisher","first-page":"Cd007506","DOI":"10.1002\/14651858.CD007506.pub3","article-title":"Lifestyle changes in women with polycystic ovary syndrome","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121605120262500_ref81","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1038\/ncomms8502","article-title":"Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations","volume":"6","author":"Hayes","year":"2015","journal-title":"Nat Commun"},{"key":"2025121605120262500_ref82","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1210\/jc.2017-02153","article-title":"Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism","volume":"103","author":"Torres","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121605120262500_ref83","doi-asserted-by":"publisher","first-page":"e0168390","DOI":"10.1371\/journal.pone.0168390","article-title":"Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): a pilot study","volume":"12","author":"Lindheim","year":"2017","journal-title":"PLoS One"},{"key":"2025121605120262500_ref84","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"2025121605120262500_ref85","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3945\/ajcn.2010.29261","article-title":"Effect of a low glycemic index compared with a conventional healthy diet on polycystic ovary syndrome","volume":"92","author":"Marsh","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"2025121605120262500_ref86","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jand.2012.11.018","article-title":"Dietary composition in the treatment of polycystic ovary syndrome: a systematic review to inform evidence-based guidelines","volume":"113","author":"Moran","year":"2013","journal-title":"J Acad Nutr Diet"},{"key":"2025121605120262500_ref87","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3389\/fphys.2020.00606","article-title":"Exercise interventions in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Patten","year":"2020","journal-title":"Front Physiol"},{"key":"2025121605120262500_ref88","doi-asserted-by":"publisher","first-page":"e0138793","DOI":"10.1371\/journal.pone.0138793","article-title":"Effects of high intensity interval training and strength training on metabolic, cardiovascular and hormonal outcomes in women with polycystic ovary syndrome: a pilot study","volume":"10","author":"Almenning","year":"2015","journal-title":"PLoS One"},{"key":"2025121605120262500_ref89","doi-asserted-by":"publisher","first-page":"Cd003053","DOI":"10.1002\/14651858.CD003053.pub6","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, d-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"11","author":"Morley","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121605120262500_ref90","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/dom.16422","article-title":"Metformin use in women with polycystic ovary syndrome (PCOS): opportunities, benefits, and clinical challenges","volume":"27","author":"Saadati","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"2025121605120262500_ref91","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr Rev"},{"key":"2025121605120262500_ref92","doi-asserted-by":"publisher","first-page":"2042018818805674","DOI":"10.1177\/2042018818805674","article-title":"Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome","volume":"10","author":"Alalami","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"key":"2025121605120262500_ref93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.metabol.2017.05.001","article-title":"Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: a meta-analysis comparing products containing cyproterone acetate with third generation progestins","volume":"73","author":"Amiri","year":"2017","journal-title":"Metab Clin Exp"},{"key":"2025121605120262500_ref94","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.2147\/TCRM.S89737","article-title":"Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndrome","volume":"11","author":"Yang","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"2025121605120262500_ref95","doi-asserted-by":"publisher","first-page":"e2011995","DOI":"10.1001\/jamanetworkopen.2020.11995","article-title":"Association of metformin with pregnancy outcomes in women with polycystic ovarian syndrome undergoing in vitro fertilization: a systematic review and meta-analysis","volume":"3","author":"Wu","year":"2020","journal-title":"JAMA Netw Open"},{"key":"2025121605120262500_ref96","doi-asserted-by":"publisher","first-page":"Cd010287","DOI":"10.1002\/14651858.CD010287.pub3","article-title":"Aromatase inhibitors (letrozole) for subfertile women with polycystic ovary syndrome","volume":"2018","author":"Franik","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121605120262500_ref97","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1056\/NEJMoa1313517","article-title":"Letrozole versus clomiphene for infertility in the polycystic ovary syndrome","volume":"371","author":"Legro","year":"2014","journal-title":"N Engl J Med"},{"key":"2025121605120262500_ref98","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.rbmo.2015.09.015","article-title":"Twenty years of ovulation induction with metformin for PCOS; what is the best available evidence?","volume":"32","author":"Abu","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"2025121605120262500_ref99","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1530\/EC-17-0243","article-title":"Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials","volume":"6","author":"Unfer","year":"2017","journal-title":"Endocr Connect"},{"key":"2025121605120262500_ref100","doi-asserted-by":"publisher","first-page":"111468","DOI":"10.1016\/j.biopha.2021.111468","article-title":"Effect and mechanism of berberine against polycystic ovary syndrome","volume":"138","author":"Zhang","year":"2021","journal-title":"Biomed Pharmacothe"},{"key":"2025121605120262500_ref101","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s00011-020-01354-w","article-title":"Inflammasome activation in podocytes: a new mechanism of glomerular diseases","volume":"69","author":"Xiong","year":"2020","journal-title":"Inflamm Res"},{"key":"2025121605120262500_ref102","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/cen.13968","article-title":"Effects of empagliflozin on metabolic parameters in polycystic ovary syndrome: a randomized controlled study","volume":"90","author":"Javed","year":"2019","journal-title":"Clin Endocrinol"},{"key":"2025121605120262500_ref103","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/17512433.2023.2274536","article-title":"The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver disease","volume":"16","author":"Tsiampali","year":"2023","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025121605120262500_ref104","doi-asserted-by":"publisher","first-page":"Cd012650","DOI":"10.1002\/14651858.CD012650.pub2","article-title":"Pharmacological and non-pharmacological strategies for obese women with subfertility","volume":"3","author":"Taghavi","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2025121605120262500_ref105","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1128\/mSystems.00017-19","article-title":"Probiotic bifidobacterium lactis v9 regulates the secretion of sex hormones in polycystic ovary syndrome patients through the gut-brain axis","volume":"4","author":"Zhang","year":"2019","journal-title":"mSystems"},{"key":"2025121605120262500_ref106","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13048-018-0457-1","article-title":"The effects of probiotic and selenium co-supplementation on parameters of mental health, hormonal profiles, and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome","volume":"11","author":"Jamilian","year":"2018","journal-title":"J Ovarian Res"},{"key":"2025121605120262500_ref107","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jad.2018.05.027","article-title":"The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome","volume":"238","author":"Jamilian","year":"2018","journal-title":"J Affect Disord"},{"key":"2025121605120262500_ref108","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.dsx.2020.01.002","article-title":"The effects of curcumin supplementation on oxidative stress, sirtuin-1 and peroxisome proliferator activated receptor \u03b3 coactivator 1\u03b1 gene expression in polycystic ovarian syndrome (PCOS) patients: a randomized placebo-controlled clinical trial","volume":"14","author":"Heshmati","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"2025121605120262500_ref109","doi-asserted-by":"publisher","first-page":"E185","DOI":"10.1210\/jc.2012-2471","article-title":"Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry","volume":"98","author":"Mutharasan","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2025121605120262500_ref110","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12978-021-01207-7","article-title":"Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis","volume":"18","author":"Zhao","year":"2021","journal-title":"Reprod Health"},{"key":"2025121605120262500_ref111","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/gim.2016.80","article-title":"Prediction of CYP2D6 phenotype from genotype across world populations","volume":"19","author":"Gaedigk","year":"2017","journal-title":"Genet Med"},{"key":"2025121605120262500_ref112","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1080\/17512433.2022.2118714","article-title":"Effects of single-nucleotide polymorphism on the pharmacokinetics and pharmacodynamics of metformin","volume":"15","author":"Li","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2025121605120262500_ref113","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13148-019-0657-6","article-title":"DNA methylome profiling of granulosa cells reveals altered methylation in genes regulating vital ovarian functions in polycystic ovary syndrome","volume":"11","author":"Sagvekar","year":"2019","journal-title":"Clin Epigenetics"},{"key":"2025121605120262500_ref114","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.tem.2020.02.002","article-title":"Inositols in polycystic ovary syndrome: an overview on the advances","volume":"31","author":"Facchinetti","year":"2020","journal-title":"Trends Endocrinol Metab"},{"key":"2025121605120262500_ref115","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ncrna.2019.04.001","article-title":"Non-coding RNA regulation in reproduction: their potential use as biomarkers","volume":"4","author":"Robles","year":"2019","journal-title":"Non-coding RNA Res"},{"key":"2025121605120262500_ref116","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13048-016-0298-8","article-title":"Circulatory microRNA 23a and microRNA 23b and polycystic ovary syndrome (PCOS): the effects of body mass index and sex hormones in an Eastern Han Chinese population","volume":"10","author":"Xiong","year":"2017","journal-title":"J Ovarian Res"},{"key":"2025121605120262500_ref117","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"2025121605120262500_ref118","doi-asserted-by":"publisher","first-page":"1298628","DOI":"10.3389\/fendo.2024.1298628","article-title":"Predicting polycystic ovary syndrome with machine learning algorithms from electronic health records","volume":"15","author":"Zad","year":"2024","journal-title":"Front Endocrinol"},{"key":"2025121605120262500_ref119","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13048-024-01407-2","article-title":"CAPN2 correlates with insulin resistance states in PCOS as evidenced by multi-dataset analysis","volume":"17","author":"Luo","year":"2024","journal-title":"J Ovarian Res"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biolreprod\/advance-article-pdf\/doi\/10.1093\/biolre\/ioaf197\/64164543\/ioaf197.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-pdf\/113\/6\/1340\/64164543\/ioaf197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-pdf\/113\/6\/1340\/64164543\/ioaf197.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T10:12:12Z","timestamp":1765879932000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article\/113\/6\/1340\/8244406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,30]]},"references-count":119,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,8,30]]},"published-print":{"date-parts":[[2025,12,16]]}},"URL":"https:\/\/doi.org\/10.1093\/biolre\/ioaf197","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,8,30]]}}}